🚀 VC round data is live in beta, check it out!
Biosynex Valuation Multiples
Discover revenue and EBITDA valuation multiples for Biosynex and similar public comparables like Iridex, Genomtec, Wellgistics Health, Episurf Medical and more.
Biosynex Overview
About Biosynex
Biosynex SA is engaged in the research, development, and manufacturing of fast diagnosis tests on membrane support for health professionals. It manufactures and markets medical devices for screening, diagnosis.
Founded
2005
HQ
Employees
128
Website
Financials (FY)
EV
$80M
Biosynex Financials
Biosynex reported last fiscal year revenue of $119M and negative EBITDA of ($22K).
In the same fiscal year, Biosynex generated $68M in gross profit, ($22K) in EBITDA losses, and had net loss of ($51M).
Biosynex P&L
In the most recent fiscal year, Biosynex reported revenue of $119M and EBITDA of ($22K).
Biosynex expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $119M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $68M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 57% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($22K) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (0%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (36%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($51M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (43%) | XXX | XXX | XXX |
| Net Debt | — | — | $66M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Biosynex Stock Performance
Biosynex has current market cap of $19M, and enterprise value of $80M.
Market Cap Evolution
Biosynex's stock price is $1.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $80M | $19M | 1.6% | XXX | XXX | XXX | $-2.77 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBiosynex Valuation Multiples
Biosynex trades at 0.7x EV/Revenue multiple, and (3586.0x) EV/EBITDA.
Biosynex Financial Valuation Multiples
As of April 20, 2026, Biosynex has market cap of $19M and EV of $80M.
Equity research analysts estimate Biosynex's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Biosynex has a P/E ratio of (0.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $19M | XXX | $19M | XXX | XXX | XXX |
| EV (current) | $80M | XXX | $80M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (3586.0x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (1.9x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.2x | XXX | XXX | XXX |
| P/E | — | XXX | (0.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (4.6x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Biosynex Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Biosynex Margins & Growth Rates
Biosynex's revenue in the last fiscal year grew by 9%.
Biosynex's revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.9M for the same period.
Biosynex Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (0%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (100%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.9M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.9M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 93% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Biosynex Public Comps
See public comps and valuation multiples for other Medical Devices and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Biosynex | XXX | XXX | XXX | XXX | XXX | XXX |
| Iridex | XXX | XXX | XXX | XXX | XXX | XXX |
| Genomtec | XXX | XXX | XXX | XXX | XXX | XXX |
| Wellgistics Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Episurf Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| SenzaGen | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Biosynex M&A Activity
Biosynex acquired XXX companies to date.
Last acquisition by Biosynex was on XXXXXXXX, XXXXX. Biosynex acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Biosynex
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBiosynex Investment Activity
Biosynex invested in XXX companies to date.
Biosynex made its latest investment on XXXXXXXX, XXXXX. Biosynex invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Biosynex
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Biosynex
| When was Biosynex founded? | Biosynex was founded in 2005. |
| Where is Biosynex headquartered? | Biosynex is headquartered in France. |
| How many employees does Biosynex have? | As of today, Biosynex has over 128 employees. |
| Is Biosynex publicly listed? | Yes, Biosynex is a public company listed on Euronext Paris. |
| What is the stock symbol of Biosynex? | Biosynex trades under ALBIO ticker. |
| When did Biosynex go public? | Biosynex went public in 2011. |
| Who are competitors of Biosynex? | Biosynex main competitors are Iridex, Genomtec, Wellgistics Health, Episurf Medical. |
| What is the current market cap of Biosynex? | Biosynex's current market cap is $19M. |
| What is the current revenue of Biosynex? | Biosynex's last fiscal year revenue is $119M. |
| What is the current EV/Revenue multiple of Biosynex? | Current revenue multiple of Biosynex is 0.7x. |
| Is Biosynex profitable? | No, Biosynex is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.